References to the "Company," "our," "us" or "we" refer to Executive Network Partnering Corporation. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.


                                       55

--------------------------------------------------------------------------------

Table of Contents

Cautionary Note Regarding Forward-Looking Statements



This Annual Report on Form
10-K
includes forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"). We have based these
forward-looking statements on our current expectations and projections about
future events. These forward-looking statements are subject to known and unknown
risks, uncertainties and assumptions about us that may cause our actual results,
levels of activity, performance or achievements to be materially different from
any future results, levels of activity, performance or achievements expressed or
implied by such forward-looking statements. In some cases, you can identify
forward-looking statements by terminology such as "may," "should," "could,"
"would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or
the negative of such terms or other similar expressions. Such statements
include, but are not limited to, possible partnering transactions and the
financing thereof, and related matters, as well as all other statements other
than statements of historical fact included in this Form
10-K.
Factors that might cause or contribute to such a discrepancy include, but are
not limited to, those described in our other Securities and Exchange Commission
("SEC") filings.

Overview

We are a blank check company incorporated in Delaware on June 22, 2020 for the purpose of identifying a company to partner with in order to effectuate a merger, share exchange, asset acquisition, share purchase, reorganization or similar partnering transaction with one or more businesses ("Partnering Transaction"). We may pursue a Partnering Transaction in any business or industry but expect to focus on a business where we believe our strong network, operational background, and aligned economic structure will provide us with a competitive advantage. Our sponsor is ENPC Holdings, LLC, a Delaware limited liability company (our "Sponsor").


Our registration statements for our initial public offering (the "Initial Public
Offering") became effective on September 15, 2020. On September 18, 2020, we
consummated the Initial Public Offering of 16,560,000 (41,400,000 after giving
effect to the Stock Split) CAPS
TM
(with respect to the Class A common stock included in the CAPS
TM
being offered, the "Public Shares"), which included 2,160,000 CAPS
TM
(5,400,000 CAPS
TM
after giving effect to the Stock Split) issued as a result of the underwriters'
exercise in full of their over-allotment option, at $25.00 per CAPS
TM
($10.00 per CAPS
TM
after giving effect to the Stock Split), generating gross proceeds of
$414.0 million, and incurring offering costs of approximately $4.8 million.

Concurrently with the closing of the Initial Public Offering, we completed the
private sale of 245,600 (614,000 after giving effect to the Stock Split) private
placement CAPS
TM
("Private Placement CAPS
TM
"), at a price of $25.00 per Private Placement CAPS
TM
($10.00 per Private Placement CAPS
TM
after giving effect to the Stock Split) to the Sponsor (the "Private
Placement"), generating gross proceeds to us of approximately $6.1 million.

Upon the closing of the Initial Public Offering and the sale of Private
Placement CAPS
TM
, $414.0 million ($10.00 per CAPS
TM
after giving effect to the Stock Split) of the net proceeds of the sale of the
CAPS
TM
in the Initial Public Offering and the Private Placement were placed in a trust
account ("Trust Account") located in the United States with Continental Stock
Transfer & Trust Company acting as trustee, and held as cash or invested only in
U.S. "government securities," within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or in money
market funds meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of
Rule
2a-7
under the Investment Company Act, which invest only in direct U.S. government
treasury obligations, as determined by us, until the earlier of: (i) the
completion of a Partnering Transaction and (ii) the distribution of the Trust
Account as described below.

We have 24 months from the closing of the Initial Public Offering, or
September 18, 2022 (or 27 months, or December 18, 2022, if we have executed a
letter of intent, agreement in principle or definitive agreement for the
Partnering Transaction within 24 months) to complete its initial Partnering
Transaction (the "Partnering Period"). If we do not complete a Partnering
Transaction within this period of time (and stockholders do not approve an
amendment to the certificate of incorporation to extend this date), we will
(i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a
per-share
price, payable in cash, of $25.00, and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of the remaining shareholders
and our board of directors, liquidate and dissolve, subject in the case of
clauses (ii) and (iii), to our obligations under Delaware law to provide for
claims of creditors and in all cases subject to the other requirements of
applicable law.

                                       56

--------------------------------------------------------------------------------

Table of Contents

Results of Operations



Our entire activity since inception through December 31, 2021 related to our
formation, the preparation for the Initial Public Offering, and since the
closing of the Initial Public Offering, the search for a prospective initial
Partnering Transaction. We have neither engaged in any operations nor generated
any revenues to date. We will not generate any operating revenues until after
completion of our initial Partnering Transaction, at the earliest. We will
generate
non-operating
income in the form of interest income on investments held in the Trust Account.
We expect to incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance), as well as for
due diligence expenses.

For the year ended December 31, 2021, we had net income of approximately $1.5 million, which consisted of an approximately $3.8 million gain from changes in fair value of warrant liabilities and approximately $41,000 in interest earned from investments held in the Trust Account, partially offset by approximately $2.0 million in general and administrative expenses, $240,000 of related party administrative fees and approximately 159,000 of franchise tax expense.

For the period from June 22, 2020 (inception) through December 31, 2020, we had net income of approximately $2.3 million, which consisted of approximately $173,000 in general and administrative costs, $80,000 of related party administrative fees, approximately $104,000 of franchise tax expense and approximately $182,000 of offering costs associated with derivative warrant liabilities, partially offset by approximately $12,000 of interest income on investments held in Trust Account and approximately $2.8 million gain from changes in fair value of derivative warrant liabilities.

Going Concern

As of December 31, 2021, we had approximately $94,000 in our operating bank account and a working capital deficit of approximately $896,000. Interest income earned on investment held in the Trust Account may be used by us to pay our franchise and income tax obligations. We intend to use substantially all of the funds held in the Trust Account to complete the initial Partnering Transaction and to pay our expenses relating thereto. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete the initial Partnering Transaction, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.



Our liquidity needs up to the closing of the Initial Public Offering and the
sale of Private Placement CAPS
TM
had been satisfied through a capital contribution of $25,000 from our Sponsor to
purchase Class F and Class B common stock, a certain portion of the net proceeds
from the consummation of the Private Placement not held in the Trust Account,
and a loan under our note agreement with our Sponsor of approximately $171,000
(the "Note") to cover for offering costs in connection with the Initial Public
Offering, we fully repaid the Note on September 22, 2020. In addition, in order
to finance transaction costs in connection with a Partnering Transaction, our
officers, directors and initial stockholders may, but are not obligated to,
provide us working capital loans (the "Working Capital Loans"). As of
December 31, 2021 and 2020, we had $430,000 and $0 note outstanding under the
Working Capital Loans.

In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," we have until September 18, 2022 to consummate a Partnering Transaction. It is uncertain that we will be able to consummate a Partnering Transaction by this time. If a Partnering Transaction is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Partnering Transaction not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. Management intends to complete the Business Combination prior to the liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after September 18, 2022.


                                       57

--------------------------------------------------------------------------------

Table of Contents

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Related Party Transactions

Founder Shares and Performance Shares

On June 22, 2020, the Sponsor paid for certain offering costs on behalf of us in exchange for (i) 737,789 Class F common stock (the "Founder Shares") in exchange for a capital contribution of $ 6,250, or approximately $0.008 per share and (ii) 1,200 shares of Class B common stock (the "Performance Shares") for a capital contribution of $18,750, or $15.625 per share. On July 17, 2020 and March 24, 2021, we effected a 100:1 and a 2.5:1 forward stock split for each share of Class B common stock, respectively, resulting in an aggregate of 300,000 Performance Shares outstanding. On July 29, 2020, we effected a reverse stock split for Class F common stock, resulting in an aggregate of 690,000 shares of Class F common stock. On September 17, 2020, we effected a 1 for 1.2 forward stock split that increased the outstanding Class F common stock from 690,000 shares to 828,000 shares. All shares and associated amounts have been retroactively restated to reflect the stock split. Of the 828,000 Founder Shares outstanding, up to 108,000 of the Founder Shares would be forfeited depending on the extent to which the underwriter's over-allotment is exercised, so that such Founder Shares would represent 5% of the outstanding shares issued in the Initial Public Offering. The underwriters fully exercised their over-allotment option on September 18, 2020; thus, these 108,000 Founder Shares were no longer subject to forfeiture. The Founder Shares are entitled to (together with the Performance Shares) a number of votes representing 20% of our outstanding common stock (not including the private placement shares) prior to the completion of the Partnering Transaction. As of December 31, 2021 and 2020, after giving effect to the 2.5:1 forward stock split for each share of Class B common stock, which was effective on March 24, 2021, we had an aggregate of 828,000 and 300,000 shares of Class F common stock and Class B common stock, respectively, issued and outstanding.

The Initial Stockholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (i) 180 days after the completion of the Partnering Transaction and (ii) the date on which we completes a liquidation, merger, capital stock exchange or other similar transaction after the Partnering Transaction that results in all of the stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees.



Private Placement CAPS
TM

Substantially concurrently with the closing of the Initial Public Offering, we
completed the private sale of 245,600 Private Placement CAPS
TM
(614,000 Private Placement CAPS
TM
after giving effect to the Stock Split), at a price of $25.00 per Private
Placement CAPS
TM
($10.00 per Private Placement CAPS
TM
after giving effect to the Stock Split) to the Sponsor, generating gross
proceeds to us of approximately $6.1 million.

Each Private Placement CAPS
TM
consists of one share of Class A common stock and
one-quarter
of one redeemable warrant (each, a "Private Placement Warrant"). Each Private
Placement Warrant entitles the holder to purchase one share of Class A common
stock at $28.75 per share ($11.50 per share after giving effect to the Stock
Split). A portion of the proceeds from the sale of the Private Placement CAPS
TM
was added to the proceeds from the Initial Public Offering held in the Trust
Account. If we do not complete a Partnering Transaction, then the proceeds will
be part of the liquidating distribution to the Public Stockholders and the
warrants will expire worthless.

Related Party Loans

On June 22, 2020, the Sponsor agreed to loan us up to an aggregate of $300,000 pursuant to an unsecured promissory note to cover expenses related to the Initial Public Offering. This loan was payable without interest upon the completion of the Initial Public Offering. We borrowed $171,000 under the Note and fully repaid the Note on September 22, 2020.


                                       58

--------------------------------------------------------------------------------

Table of Contents



In order to finance transaction costs in connection with an intended initial
Partnering Transaction, the Sponsor or an affiliate of the Sponsor or certain of
our officers and directors may, but are not obligated to, loan us funds as may
be required (the "Working Capital Loans"). Up to $1.5 million of such loans may
be convertible into Private Placement CAPS
TM
at a price of $25.00 per Private Placement CAPS
TM
($10.00 per Private Placement CAPS
TM
after giving effect to the Stock Split) at the option of the lender. The Working
Capital CAPS
TM
would be identical to the Private Placement CAPS
TM
issued to the Sponsor. Except as described below, the terms of such loans, if
any, have not been determined and no written agreements exist with respect to
such loans.

On September 23, 2021, the Company issued a Working Capital Loan to the Sponsor,
pursuant to which the Company borrowed $180,000 for ongoing expenses reasonably
related to the business of the Company and the consummation of the Partnering
Transaction. On October 27, 2021, the Company issued a Working Capital Loan to
the Sponsor, pursuant to which the Company borrowed $180,000 for ongoing
expenses reasonably related to the business of the Company and the consummation
of the Partnering Transaction. The Working Capital Loans do not bear any
interest. All unpaid principal under the Working Capital Loans will be due and
payable in full on the earlier of (i) January 11, 2023 and (ii) the effective
date of the Partnering Transaction (such earlier date, the "Maturity Date"). The
Sponsor will have the option, at the time of consummation of a Partnering
Transaction, to convert any amounts outstanding under the Working Capital Loans
into Working Capital CAPS
TM
.

During the year ended December 31, 2021, we borrowed from Sponsor total of $430,000 pursuant to the Working Capital Loans for ongoing expenses reasonably related to the business of us and the consummation of the Partnering Transaction. The Working Capital Loans do not bear any interest. As of December 31, 2021 and 2020, $430,000 and $0 note outstanding under the Working Capital Loans.

Administrative Services Agreement

Commencing on the date that our securities were first listed on the New York Stock Exchange through the earlier of consummation of the Partnering Transaction and our liquidation, we will pay an affiliate of the Sponsor for office space, secretarial and administrative services provided to members of our management team $20,000 per month. We incurred $240,000 and $80,000 in expenses in connection with such services during year ended December 31, 2021 and for the period from June 22, 2020 (inception) through December 31, 2020, as reflected in related party general and administrative expenses in the accompanying statements of operations. As of December 31, 2021 and 2020, we had approximately $0 and $80,000 in accounts payable in connection with such services as reflected in the accompanying balance sheets.



In addition, the Sponsor, executive officers and directors, or any of their
respective affiliates will be reimbursed for any
out-of-pocket
expenses incurred in connection with activities on our behalf such as
identifying potential target businesses and performing due diligence on suitable
Partnering Transactions. Our audit committee will review on a quarterly basis
all payments that were made to the Sponsor, executive officers or directors, or
their affiliates.

Other Contractual Obligations



The holders of the Founder Shares, Performance Shares, private placement
warrants and private placement shares underlying Private Placement CAPS
TM
and private placement CAPS
TM
that may be issued upon conversion of Working Capital Loans (and any shares of
Class A common stock into which such securities may convert and that may be
issued upon exercise of private placement warrants) are entitled to registration
rights pursuant to a registration rights agreement, requiring us to register
such securities for resale. The holders of these securities are entitled to make
up to three demands, excluding short form demands, that we register such
securities. In addition, the holders have certain "piggy-back" registration
rights with respect to registration statements filed subsequent to the
completion of the Partnering Transaction. We will bear the expenses incurred in
connection with the filing of any such registration statements.

In September 2020, we engaged Evercore as a capital markets advisor in connection with the Partnering Transaction, to assist us with the potential Partnering Transaction. We agreed to pay Evercore for such services upon the consummation of the Partnering Transaction a cash fee in an amount equal to 2.25% of the gross proceeds of the Initial Public Offering (exclusive of any applicable finders' fees which might become payable), which equates to approximately $9.3 million. Pursuant to the terms of the capital markets advisory agreement, no fee will be due if we do not complete a Partnering Transaction.

Critical Accounting Policies and Estimates

This management's discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We has identified the following as its critical accounting policies:


                                       59

--------------------------------------------------------------------------------

Table of Contents

Class A Common Stock Subject to Possible Redemption Class A common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders' equity. Our Class A common stock features certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2021 and 2020, 41,400,000 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders' equity section of our balance sheets.



Under ASC 480, we have elected to recognize changes in the redemption value
immediately as they occur and adjust the carrying value of the security to equal
the redemption value at the end of each reporting period. This method would view
the end of the reporting period as if it were also the redemption date for the
security. Immediately upon the closing of the Initial Public Offering, we
recognized the accretion from initial book value to redemption amount value. The
change in the carrying value of the redeemable Class A common stock resulted in
charges against additional
paid-in
capital (to the extent available) and accumulated deficit.

Net Income per Share of Common Stock

We comply with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." We have three classes of shares, which are referred to as Class A common stock, Class B common stock and Class F common stock. Income and losses are shared pro rata among the three classes of shares. Net income (loss) per share of common stock is calculated by dividing the net income (loss) by the weighted average number of common stock outstanding for the respective period. The calculation of diluted net income per share of common stock does not consider the effect of the warrants underlying the CAPS TM sold in the Initial Public Offering and the Private Placement Warrants to purchase 10,503,500 shares of Class A common stock in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share of common stock is the same as basic net income per share of common stock for the year ended December 31, 2021 and for the period from June 22, 2020 (inception) through December 31, 2020. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

Derivative Warrant Liabilities


We do not use derivative instruments to hedge exposures to cash flow, market or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC
815-15.
The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.

We issued 10,350,000 warrants to purchase Class A common stock to investors in
our Initial Public Offering and issued 153,500 Private Placement Warrants. All
of our outstanding warrants are recognized as derivative liabilities in
accordance with ASC
815-40.
Accordingly, we recognize the warrant instruments as liabilities at fair value
and adjust the instruments to fair value at each reporting period. The
liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is
recognized in our statements of operations. The fair value of the warrants
issued in connection with the Initial Public Offering was initially measured
using a Monte-Carlo simulation model and subsequently been measured based on the
listed market price of such warrants at each measurement date when separately
listed and traded. The fair value of the warrants issued in connection with the
Private Placement have been estimated using a Black-Scholes Option Pricing model
at each measurement date. The determination of the fair value of the warrant
liability may be subject to change as more current information becomes available
and, accordingly, the actual results could differ significantly. Derivative
warrant liabilities are classified as
non-current
liabilities, as their liquidation is not reasonably expected to require the use
of current assets or require the creation of current liabilities.

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging -Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity ("ASU 2020-06"), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. We adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact our financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material impact on our financial statements.

Off-Balance

Sheet Arrangements



As of December 31, 2021, we did not have any
off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation
S-K
and did not have any commitments or contractual obligations.

                                       60

--------------------------------------------------------------------------------

Table of Contents

JOBS Act



The Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") contains
provisions that, among other things, relax certain reporting requirements for
qualifying public companies. We qualify as an "emerging growth company" and
under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded)
companies. We are electing to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting
standards on the relevant dates on which adoption of such standards is required
for
non-emerging
growth companies. As a result, the financial statements may not be comparable to
companies that comply with new or revised accounting pronouncements as of public
company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an "emerging growth company," we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor's attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO's compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an "emerging growth company," whichever is earlier.

© Edgar Online, source Glimpses